Basis of Presentation - (Details) |
3 Months Ended |
|---|---|
|
Mar. 31, 2021
shares
| |
| Number of UPO units exchanged | 3,004,030 |
| Number of shares in exchange for UPO units | 37,687 |
| Warrant [Member] | |
| Antidilutive securities excluded from computation of earnings per share | 75,000 |
| Common Stock [Member] | |
| Antidilutive securities excluded from computation of earnings per share | 15,095,000 |
| Common Stock [Member] | Over-Allotment Option [Member] | |
| Antidilutive securities excluded from computation of earnings per share | 75,000 |
| Restricted Stock [Member] | |
| Antidilutive securities excluded from computation of earnings per share | 2,355,700 |
| X | ||||||||||
- Definition Number of shares in exchange for UPO units. No definition available.
|
| X | ||||||||||
- Definition Number of UPO units exchanged. No definition available.
|
| X | ||||||||||
- Definition Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|